首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 核酸药物

市场调查报告书

商品编码

1905225

日本胜肽类药物市场报告（按类型、製造商类型、合成技术、给药途径、应用和地区划分，2026-2034年）

Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本肽类药物市场规模达27.578亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到48.036亿美元，2026年至2034年间的复合年增长率（CAGR）为6.36%。推动市场成长的主要因素包括：人们对快速且精准的糖尿病治疗方法的需求不断增长，以及人们越来越倾向于透过美容手术来延缓皮肤老化。

本报告解答的关键问题：

日本肽类药物市场目前表现如何？未来几年又将如何发展？
新冠疫情对日本胜肽类药物市场产生了哪些影响？
日本肽类药物市场按类型分類的组成是怎样的？
日本胜肽类药物市场依生产者类型分類的组成是怎样的？
日本肽类药物市场依合成技术分類的组成是怎样的？
日本肽类药物市场依给药途径分類的组成是怎样的？
日本肽类药物市场按应用领域分類的组成是怎样的？
日本肽类药物市场价值链的各阶段有哪些？
日本肽类药物治疗的关键驱动因素和挑战是什么？
日本肽类药物市场的结构是怎么样的？主要参与者有哪些？
日本肽类药物市场的竞争程度如何？

Japan peptide therapeutics market size reached USD 2,757.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,803.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.36% during 2026-2034. The inflating need for fast and precise treatment methods to cure diabetes, along with the increasing inclination among individuals towards cosmetic procedures to mitigate the effects of skin aging, is primarily driving the market growth.

Peptides are highly effective and specific signaling molecules that attach to particular cell surface receptors, including ion channels and G protein-coupled receptors (GPCRs), initiating intracellular responses. In the pharmaceutical sector, they are utilized to develop innovative regenerative therapies capable of targeting various types of cells and influencing their reactions. These therapies, in comparison to other treatment alternatives, are less toxic, generally safe, and well-tolerated. Consequently, they are becoming increasingly popular in clinical applications throughout Japan for the treatment of conditions such as cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Japan Peptide Therapeutics Market Trends:

The increasing prevalence of both acute and chronic illnesses, alongside improved access to medical services, stands as a prominent factor that is positively impacting the demand for peptides in the development of innovative therapies, which is primarily driving the market growth. Additionally, peptides are employed in cosmeceutical procedures to mitigate the effects of skin aging. This, combined with the growing awareness among individuals about their physical appearance and the desire to maintain youthful and healthy skin, is propelling the adoption of cosmetic treatments and peptide-based therapeutics worldwide. Furthermore, the introduction of new synthetic techniques that reduce the frequency of injections and enhance the stability and other physical attributes of peptide therapeutics has led to their widespread use in injections for diabetic patients. This, in conjunction with the increasing incidence of diabetes and a preference for rapid and precise treatment methods , is driving the utilization of peptide therapeutics over oral medications. Moreover, the emerging trend of personalized and targeted therapies is driving the demand for versatile peptide-based materials, which is acting as another significant growth-inducing factor. Alongside this, the growing investment in the development of novel peptide therapeutics for autoimmune and inflammatory conditions is expected to create a favorable market outlook in the coming years.

Japan Peptide Therapeutics Market Segmentation:

Type Insights:

Innovative
Generic

Type of Manufacturer Insights:

Outsourced
In-house

Synthesis Technology Insights:

Solid Phase Peptide Synthesis
Liquid Phase Peptide Synthesis
Hybrid Technology

Routes of Administration Insights:

Parenteral
Oral
Others

Application Insights:

Gastrointestinal Disorders
Neurological Disorders
Metabolic Disorders
Cancer
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan peptide therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan peptide therapeutics market?
What is the breakup of the Japan peptide therapeutics market on the basis of type?
What is the breakup of the Japan peptide therapeutics market on the basis of type of manufacturer?
What is the breakup of the Japan peptide therapeutics market on the basis of synthesis technology?
What is the breakup of the Japan peptide therapeutics market on the basis of routes of administration?
What is the breakup of the Japan peptide therapeutics market on the basis of application?
What are the various stages in the value chain of the Japan peptide therapeutics market?
What are the key driving factors and challenges in the Japan peptide therapeutics?
What is the structure of the Japan peptide therapeutics market and who are the key players?
What is the degree of competition in the Japan peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Peptide Therapeutics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Peptide Therapeutics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Peptide Therapeutics Market - Breakup by Type

6.1 Innovative
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Generic
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Peptide Therapeutics Market - Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 In-house
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Peptide Therapeutics Market - Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Hybrid Technology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan Peptide Therapeutics Market - Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2020-2025)
- 9.3.2 Market Forecast (2026-2034)

10 Japan Peptide Therapeutics Market - Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Neurological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Metabolic Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Cancer
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Forecast (2026-2034)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2020-2025)
- 10.5.2 Market Forecast (2026-2034)

11 Japan Peptide Therapeutics Market - Breakup by Region

11.1 Kanto Region
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Breakup by Type
- 11.1.4 Market Breakup by Type of Manufacturer
- 11.1.5 Market Breakup by Synthesis Technology
- 11.1.6 Market Breakup by Routes of Administration
- 11.1.7 Market Breakup by Application
- 11.1.8 Key Players
- 11.1.9 Market Forecast (2026-2034)
11.2 Kansai/Kinki Region
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Breakup by Type
- 11.2.4 Market Breakup by Type of Manufacturer
- 11.2.5 Market Breakup by Synthesis Technology
- 11.2.6 Market Breakup by Routes of Administration
- 11.2.7 Market Breakup by Application
- 11.2.8 Key Players
- 11.2.9 Market Forecast (2026-2034)
11.3 Central/ Chubu Region
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Breakup by Type
- 11.3.4 Market Breakup by Type of Manufacturer
- 11.3.5 Market Breakup by Synthesis Technology
- 11.3.6 Market Breakup by Routes of Administration
- 11.3.7 Market Breakup by Application
- 11.3.8 Key Players
- 11.3.9 Market Forecast (2026-2034)
11.4 Kyushu-Okinawa Region
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Breakup by Type
- 11.4.4 Market Breakup by Type of Manufacturer
- 11.4.5 Market Breakup by Synthesis Technology
- 11.4.6 Market Breakup by Routes of Administration
- 11.4.7 Market Breakup by Application
- 11.4.8 Key Players
- 11.4.9 Market Forecast (2026-2034)
11.5 Tohoku Region
- 11.5.1 Overview
- 11.5.2 Historical and Current Market Trends (2020-2025)
- 11.5.3 Market Breakup by Type
- 11.5.4 Market Breakup by Type of Manufacturer
- 11.5.5 Market Breakup by Synthesis Technology
- 11.5.6 Market Breakup by Routes of Administration
- 11.5.7 Market Breakup by Application
- 11.5.8 Key Players
- 11.5.9 Market Forecast (2026-2034)
11.6 Chugoku Region
- 11.6.1 Overview
- 11.6.2 Historical and Current Market Trends (2020-2025)
- 11.6.3 Market Breakup by Type
- 11.6.4 Market Breakup by Type of Manufacturer
- 11.6.5 Market Breakup by Synthesis Technology
- 11.6.6 Market Breakup by Routes of Administration
- 11.6.7 Market Breakup by Application
- 11.6.8 Key Players
- 11.6.9 Market Forecast (2026-2034)
11.7 Hokkaido Region
- 11.7.1 Overview
- 11.7.2 Historical and Current Market Trends (2020-2025)
- 11.7.3 Market Breakup by Type
- 11.7.4 Market Breakup by Type of Manufacturer
- 11.7.5 Market Breakup by Synthesis Technology
- 11.7.6 Market Breakup by Routes of Administration
- 11.7.7 Market Breakup by Application
- 11.7.8 Key Players
- 11.7.9 Market Forecast (2026-2034)
11.8 Shikoku Region
- 11.8.1 Overview
- 11.8.2 Historical and Current Market Trends (2020-2025)
- 11.8.3 Market Breakup by Type
- 11.8.4 Market Breakup by Type of Manufacturer
- 11.8.5 Market Breakup by Synthesis Technology
- 11.8.6 Market Breakup by Routes of Administration
- 11.8.7 Market Breakup by Application
- 11.8.8 Key Players
- 11.8.9 Market Forecast (2026-2034)

12 Japan Peptide Therapeutics Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Peptide Therapeutics Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis

15 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本胜肽类药物市场报告（按类型、製造商类型、合成技术、给药途径、应用和地区划分，2026-2034年）

Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2026-2034

本报告解答的关键问题：

目录

第一章：序言

第二章：范围与方法

第三章：执行概要

第四章：日本胜肽类药物市场－简介

第五章：日本胜肽类药物市场概况

第六章：日本胜肽类药物市场－按类型划分

第七章：日本胜肽类药物市场－依生产者类型划分

第八章：日本胜肽类药物市场－依合成技术划分

第九章：日本胜肽类药物市场－依给药途径划分

第十章：日本胜肽类药物市场－依应用领域划分

第十一章：日本胜肽类药物市场－按地区划分

第十二章：日本胜肽类药物市场－竞争格局

第十三章：关键参与者简介

第十四章：日本胜肽类药物市场—产业分析

第十五章：附录